Singapore-based engineering services provider Acromec has listed on SGX’s Catalist, opening Monday morning at S$0.25 ($0.18), according to a filing.
The initial public offering (IPO) was said to be 5.3 times oversubscribed, according to a report on HealthInvestor Asia. The company had secured $4.4 million from selling 27 million new shares at S$0.22 each, and a market capitalisation of around S$26.5 million after its listing.
